![Hsing I Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hsing I Chen began roles at Elixiron Immunotherapeutics (Cayman) Ltd. and PharmaEssentia Corp.
in 2025.
At Elixiron Immunotherapeutics (Cayman) Ltd., the role is Independent Director starting in 2025.
At PharmaEssentia Corp., the role is Chief Legal Officer starting in 2025.
Both roles are current.
| Empresas | Cargo | Inicio |
|---|---|---|
| ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED | Director/Miembro de la Junta | 23/10/2025 |
| PHARMAESSENTIA CORPORATION | Consejero General | 09/05/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
PharmaEssentia Corp.
 PharmaEssentia Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutic products for the treatment of hematologic diseases | Health Technology |
Elixiron Immunotherapeutics, Inc.
 Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision immunotherapy drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
